EP3229759A1 - Émulsion de déodorant contenant un mélange d'alkylpolyglycoside et d'alcool gras, un polyuréthane-polyéther non ionique associatif, une huile à base d'hydrocarbure volatil - Google Patents

Émulsion de déodorant contenant un mélange d'alkylpolyglycoside et d'alcool gras, un polyuréthane-polyéther non ionique associatif, une huile à base d'hydrocarbure volatil

Info

Publication number
EP3229759A1
EP3229759A1 EP15808602.5A EP15808602A EP3229759A1 EP 3229759 A1 EP3229759 A1 EP 3229759A1 EP 15808602 A EP15808602 A EP 15808602A EP 3229759 A1 EP3229759 A1 EP 3229759A1
Authority
EP
European Patent Office
Prior art keywords
alcohol
emulsion
oil
volatile
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15808602.5A
Other languages
German (de)
English (en)
Inventor
Francine Baldo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP3229759A1 publication Critical patent/EP3229759A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/548—Associative polymers

Definitions

  • the present invention relates to an oil-in-water emulsion containing:
  • At least one mixture comprising at least one alkylpolyglycoside whose alkyl chain is linear or branched and comprises from 12 to 22 carbon atoms and at least one linear or branched fatty alcohol, having from 12 to 22 carbon atoms; d) at least one associative nonionic polyether polyurethane;
  • the present invention also relates to a method for the treatment of body odor and optionally of human perspiration, which consists in applying to a keratin material an emulsion as defined previously.
  • a method for the treatment of body odor and optionally of human perspiration which consists in applying to a keratin material an emulsion as defined previously.
  • deodorant products containing active substances such as antiperspirants, bactericides or odor-absorbers for reducing or even preventing body odor, in particular the generally unpleasant underarm odor.
  • Many different types of deodorant compositions have been described in the literature and have appeared on the market in forms such as gels, sticks, creams, roll-ons or aerosols.
  • deodorant creams three major types of formulation exist: anhydrous or soft solid formulations, water-in-oil emulsions and oil-in-water emulsions.
  • the soft solid anhydrous formulations and water-in-oil emulsions that are continuous oil-based substrates present the drawback of producing a greasy sensation upon application and a lack of fresh sensation or even insufficient deodorant effectiveness.
  • Deodorant oil-in-water emulsions with a continuous aqueous phase that are packaged in the form of roll-on balls are particularly sought after for their original cosmetic qualities in terms of the fresh sensation on the skin after application.
  • compositions are not completely satisfactory in terms of sensorial properties because they may lead to a perceptible sticky effect for the consumer. Therefore a need exists for finding new deodorant formulations that can be packaged in the form of roll-ons having good efficacy and in which the sticky effect is appreciably reduced relative to formulations known from the prior art.
  • At least one mixture comprising at least one alkylpolyglycoside whose alkyl chain is linear or branched and comprises from 12 to 22 carbon atoms and at least one linear or branched fatty alcohol, having from 12 to 22 carbon atoms; d) at least one associative nonionic polyether polyurethane;
  • the present invention therefore firstly relates to an oil-in-water emulsion containing:
  • At least one mixture comprising at least one alkylpolyglycoside whose alkyl chain is linear or branched and comprises from 12 to 22 carbon atoms and at least one linear or branched fatty alcohol, having from 12 to 22 carbon atoms; d) at least one associative nonionic polyether polyurethane;
  • the present invention secondly relates to a method for the treatment of body odor and optionally of human perspiration, which consists in applying to a keratin material an emulsion as defined previously.
  • the emulsion comprises a physiologically acceptable medium.
  • the term "physiologically acceptable medium” denotes a medium that is suitable for the topical administration of a composition, i.e. a medium which is odorless and has no unpleasant appearance, and which is perfectly compatible with the topical route of administration. Such a medium is considered to be “physiologically acceptable” when it does not cause any tingling, tautness or redness unacceptable for the user.
  • the expression “deodorant active agent” is understood to mean any substance capable of reducing, masking or absorbing human body odors, in particular underarm odors.
  • the term “oil” means a fatty substance which is liquid at room temperature (25°C) and atmospheric pressure (760 mmHg, i.e. 10 5 Pa). The oil may be volatile or non-volatile.
  • volatile oil is intended to mean an oil that is capable of evaporating on contact with the skin or the keratin fiber in less than one hour, at ambient temperature and atmospheric pressure.
  • volatile oils of the invention are volatile cosmetic oils that are liquid at ambient temperature with a non-zero vapor pressure, at ambient temperature and atmospheric pressure ranging in particular from 0.13 Pa to 40 000 Pa (10 "3 to 300 mmHg), in particular ranging from 1 .3 Pa to 13 000 Pa (0.01 to 100 mmHg) and more particularly ranging from 1 .3 Pa to 1300 Pa (0.01 to 10 mmHg).
  • hydrocarbon-based oil is intended to mean an oil mainly containing carbon and hydrogen atoms and possibly one or more functions chosen from hydroxyl, ester, ether and carboxylic functions.
  • oil-in-water means a composition comprising a continuous aqueous phase and an oil phase dispersed in the aqueous phase, where both phases are stabilized by an emulsifying system.
  • the term "associative polymer” means a hydrophilic polymer that is capable, in an aqueous medium, of reversibly combining with itself or with other molecules. Their chemical structure more particularly comprises at least one hydrophilic region and at least one hydrophobic region.
  • hydrophobic group is intended to mean a radical or polymer comprising a saturated or unsaturated and linear or branched hydrocarbon-based chain.
  • hydrophobic group denotes a hydrocarbon-based radical, it comprises at least 10 carbon atoms, preferably from 10 to 30 carbon atoms, in particular from 12 to 30 carbon atoms and more preferably from 18 to 30 carbon atoms.
  • the hydrocarbon-based group is derived from a monofunctional compound.
  • the hydrophobic group may be derived from a fatty alcohol, such as stearyl alcohol, dodecyl alcohol or decyl alcohol, or else from a polyalkylenated fatty alcohol, such as Steareth-100. It may also denote a hydrocarbon polymer, for instance polybutadiene.
  • compositions in accordance with the invention comprise at least one mixture of:
  • At least one alkylpolyglycoside whose alkyl chain is linear or branched and comprises from 12 to 22 carbon atoms and b) at least one linear or branched fatty alcohol having from 12 to 22 carbon atoms.
  • this mixture behaves as an emulsifying agent.
  • alkylpolyglycoside means an alkylmonosaccharide (degree of polymerization 1 ) or an alkylpolyglycoside (degree of polymerization greater than 1 ).
  • the emulsifying fatty alcohol/alkylpolyglycoside mixture contains:
  • alkylpolyglycosides may be used alone or in the form of mixtures of several alkylpolyglycosides. They generally correspond to the following structure:
  • R(O)(G) x in which the R substituent is a linear or branched C12-C22 alkyl substituent, G is a saccharide residue and x ranges from 1 to 5, preferably from 1 .05 to 2.5 and more preferentially from 1 .1 to 2.
  • the saccharide residue may be chosen from glucose, dextrose, saccharose, fructose, galactose, maltose, maltotriose, lactose, cellobiose, mannose, ribose, dextran, talose, allose, xylose, levoglucan, cellulose and starch. More preferentially, the saccharide residue denotes glucose.
  • each unit of the polysaccharide part of the alkylpolyglycoside may be in a or ⁇ isomer form, in L or D form, and the configuration of the saccharide residue may be of furanoside or pyranoside type.
  • alkylpolysaccharides which may differ from each other in the nature of the borne alkyl unit and/or the nature of the bearing polysaccharide chain.
  • fatty alcohols that must be used, alone or in mixtures, in combination with alkylpolysaccharides in the emulsifying mixtures in accordance with the invention can be linear or branched fatty alcohols of synthetic or alternatively of natural origin, for example alcohols derived from plant material (coconut, palm kernel, palm, etc.) or animal material (tallow, etc.). Needless to say, other long-chain alcohols may also be used, for instance ether alcohols or Guerbet alcohols.
  • fatty alcohol(s) used are chosen from those containing from 12 to 22 carbon atoms and even more preferentially from 12 to 18 carbon atoms.
  • fatty alcohols that may be used in the context of the present invention, mention may be made especially of lauryl alcohol, cetyl alcohol, myristic alcohol, stearyl alcohol, isostearyl alcohol, palmitic alcohol, oleic alcohol, behenyl alcohol and arachidyl alcohol, which may thus be taken alone or as mixtures.
  • fatty alcohol/alkylpolyglycoside emulsifying mixtures as defined above are known as such. They are described in applications WO92/06778, WO95/13863 and WO98/47610 and prepared according to the preparation processes indicated in these documents.
  • fatty alcohols/alkylpolyglycoside mixtures mention may be made of the products sold by the company SEPPIC under the name Montanov®, such as the following mixtures:
  • Isostearyl alcohol/isostearyl glucoside - Montanov WO 18® Fatty alcohol/alkylpolyglycoside mixtures chosen from the following will be preferred:
  • the fatty alcohol/alkylpolyglycoside mixture is preferably present in emulsions in accordance with the invention in concentrations ranging from 0.5% to 15% by weight and more preferentially from 1 to 10% by weight relative to the total weight of the composition.
  • non-ionic polyether polyurethanes according to the invention generally comprise, in their chain, both hydrophilic blocks, usually of polyoxyethylene nature, and hydrophobic blocks that may be aliphatic sequences alone and/or cycloaliphatic and/or aromatic sequences.
  • these polyether polyurethanes comprise at least two lipophilic hydrocarbon chains containing from 6 to 30 carbon atoms, separated by a hydrophilic block, the hydrocarbon chains possibly being pendent chains or chains at the end of the hydrophilic block.
  • the polymer may comprise a hydrocarbon-based chain at one end or at both ends of a hydrophilic block.
  • the polyurethane polyethers can be multiblock, in particular in triblock form.
  • the hydrophobic blocks can be at each end of the chain (for example: triblock copolymer having a hydrophilic central block) or distributed both at the ends and in the chain (for example, multiblock copolymer).
  • These same polymers can also be graft polymers or star polymers.
  • the nonionic fatty-chain polyurethane polyethers can be triblock copolymers, whose hydrophilic block is a polyoxyethylene chain comprising from 50 to 1000 oxyethylene groups.
  • the non-ionic polyether polyurethanes comprise a urethane linkage between the hydrophilic blocks, whence arises the name.
  • the non-ionic polyether polyurethanes comprising a hydrophobic chain are those in which the hydrophilic blocks are linked to the hydrophobic blocks via other chemical bonds.
  • non-ionic polyether polyurethanes comprising a hydrophobic chain
  • Rheolate 205® containing a urea functional group sold by the company Rheox, or Rheolate® 208, 204 or 212, and also Acrysol RM 184®.
  • the product DW 1206B® from Rohm & Haas containing a C20 alkyl chain and a urethane linkage, sold at a solids content of 20% in water, may also be used.
  • Use may also be made of solutions or dispersions of these polymers, in particular in water or in an aqueous alcohol medium.
  • examples of such polymers that may be mentioned are Rheolate® 255, Rheolate® 278 and Rheolate® 244 sold by the company Rheox.
  • Use may also be made of the products DW 1206F and DW 1206J sold by the company Rohm & Haas.
  • polyurethane polyethers that may be used according to the invention may also be chosen from those described in the article by G. Fonnum, J. Bakke and Fk. Hansen - Colloid Polym. Sci., 271 , 380-389 (1993).
  • a polyether polyurethane that may be obtained by polycondensation of at least three compounds comprising (i) at least one polyethylene glycol comprising from 150 to 180 mol of ethylene oxide, (ii) stearyl alcohol or decyl alcohol, and (iii) at least one diisocyanate.
  • Aculyn 46® having the INCI name: PEG-150/Stearyl Alcohol/SMDI Copolymer, is a polycondensate of polyethylene glycol comprising 150 or 180 mol of ethylene oxide, of stearyl alcohol and of methylenebis(4-cyclohexyl isocyanate) (SMDI) at 15% by weight in a matrix of maltodextrin (4%) and water (81 %) .
  • SMDI methylenebis(4-cyclohexyl isocyanate
  • Aculyn 44® (PEG-150/Decyl Alcohol/SMDI Copolymer) is a polycondensate of polyethylene glycol comprising 150 or 180 mol of ethylene oxide, of decyl alcohol and of methylenebis(4-cyclohexyl isocyanate) (SMDI) at 35% by weight in a mixture of propylene glycol (39%) and water (26%).
  • a polyether polyurethane that may be obtained by polycondensation of at least three compounds comprising (i) at least one polyethylene glycol comprising from 150 to 180 mol of ethylene oxide, (ii) a polyoxyethylenated stearyl alcohol comprising 100 mol of ethylene oxide, and (iii) a diisocyanate.
  • Such polyether polyurethanes are sold especially by the company Sasol Servo BV under the name SER-AD FX 1 100®, which is a polycondensate of polyethylene glycol containing 136 mol of ethylene oxide, of stearyl alcohol polyoxyethylenated with 100 mol of ethylene oxide and of hexamethylene diisocyanate (HDI) with a weight-average molecular weight of 30 000 (INCI name: PEG-136/Steareth- 1001/SMDI Copolymer).
  • SER-AD FX 1 100® is a polycondensate of polyethylene glycol containing 136 mol of ethylene oxide, of stearyl alcohol polyoxyethylenated with 100 mol of ethylene oxide and of hexamethylene diisocyanate (HDI) with a weight-average molecular weight of 30 000 (INCI name: PEG-136/Steareth- 1001/SMDI Copolymer).
  • the amount of associative polyether polyurethane as active substance may range, for example, from 0.1 to 10% by weight, preferably from 0.25 to 8% by weight and better still from 1 .5 to 5% by weight relative to the total weight of the composition.
  • DEODORANT ACTIVE AGENTS Among the deodorant active agents that can be used according to the invention, mention may be made of antiperspirant active agents.
  • antiperspirant active agent is intended to mean an active agent which, by itself, has the effect of reducing the flow of sweat, of reducing the sensation on the skin of moisture associated with human sweat and of masking human sweat.
  • antiperspirant active agents mention may be made of salts or complexes of aluminum and/or of zirconium, preferably chosen from aluminum halohydrates; aluminum zirconium halohydrates, complexes of zirconium hydroxychloride and of aluminum hydroxychloride with or without an amino acid, such as those described in patent US-3 792 068.
  • aluminum chlorohydrate in activated or unactivated form, aluminum chlorohydrex, the aluminum chlorohydrex-polyethylene glycol complex, the aluminum chlorohydrex- propylene glycol complex, aluminum dichlorohydrate, the aluminum dicnlorohydrex-polyethylene glycol complex, the aluminum dichlorohydrex- propylene glycol complex, aluminum sesquichlorohydrate, the aluminum sesquichlorohydrex-polyethylene glycol complex, the aluminum sesquichlorohydrex-propylene glycol complex, aluminum sulfate buffered with sodium aluminum lactate.
  • aluminum zirconium salts mention may be made in particular of aluminum zirconium octachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium tetrachlorohydrate and aluminum zirconium trichlorohydrate.
  • the complexes of zirconium hydroxychloride and of aluminum hydroxychloride with an amino acid are generally known as ZAG (when the amino acid is glycine).
  • Aluminum sesquichlorohydrate is in particular sold under the trade name Reach 301® by the company Summitreheis.
  • the complexes of zirconium hydroxychloride and of aluminum hydroxychloride with an amino acid such as glycine having the INCI name: Aluminum Zirconium Tetrachlorohydrex Gly, for example the product sold under the name Reach AZP- 908-SUF® by the company Summitreheis.
  • expanded perlite particles such as those obtained by the expansion process described in patent US 5,002,698.
  • the perlites which can be used according to the invention are generally aluminosilicates of volcanic origin and have the composition:
  • the perlite particles used will be ground; in this case, they are known as Expanded Milled Perlite (EMP). They preferably have a particle size defined by a median diameter D50 ranging from 0.5 to 50 ⁇ and preferably from 0.5 to 40 ⁇ .
  • EMP Expanded Milled Perlite
  • the perlite particles used have a loose bulk density at 25°C ranging from 10 to 400 kg/m 3 (standard DIN 53468) and preferably from 10 to 300 kg/m 3 .
  • the expanded perlite particles according to the invention have a water absorption capacity, measured at the wet point, ranging from 200% to 1500% and preferably from 250 to 800%.
  • the wet point corresponds to the amount of water which has to be added to 1 g of particle in order to obtain a homogeneous paste.
  • This method derives directly from the oil uptake method applied to solvents. The measurements are taken in the same manner by means of the wet point and the flow point, which have, respectively, the following definitions: wet point: mass expressed in grams per 100 g of product corresponding to the production of a homogeneous paste during the addition of a solvent to a powder; flow point: mass expressed in grams per 100 g of product above which the amount of solvent is greater than the capacity of the powder to retain it. This is reflected by the production of a more or less homogeneous mixture which flows over the glass plate.
  • the wet point and the flow point are measured according to the following protocol: Protocol for measuring the water absorption
  • the glass plate is placed on the balance and 1 g of perlite particles is weighed out.
  • the beaker containing the solvent and the liquid sampling pipette is placed on the balance.
  • the solvent is gradually added to the powder, the whole being regularly blended (every 3 to 4 drops) with the spatula.
  • the expanded perlite particles sold under the trade names Optimat 1430 OR or Optimat 2550 by the company World Minerals will be used in particular. Mention may also be made of talcs or magnesium silicates such as that sold under the name Luzenac 15 M00® by the company Luzenac.
  • the deodorant active agents may be bacteriostatic agents or bactericidal agents that act on underarm odor microorganisms, such as 2,4,4'-trichloro-2'-hydroxydiphenyl ether ( ⁇ Triclosan), 2,4-dichloro-2'-hydroxydiphenyl ether, 3',4',5'- trichlorosalicylanilide, 1 -(3',4'-dichlorophenyl)-3-(4'-chlorophenyl)urea ( ⁇ Triclocarban) or 3,7,1 1 -trimethyldodeca-2, 5,10-trienol ( ⁇ Farnesol); quaternary ammonium salts such as cetyltrimethylammonium salts, cetylpyridinium salts, DPTA (1 ,3-diaminopropanetetraacetic acid), 1 ,2-decanediol (Symclariol from
  • the deodorant active agents may be odor absorbers such as zinc ricinoleates or sodium bicarbonate; metallic or silver or silver-free zeolites, or cyclodextrins and derivatives thereof. They may also be chelating agents such as Dissolvine GL-47- S® from Akzo Nobel, EDTA and DPTA. They may also be a polyol such as glycerol or 1 ,3-propanediol (Zemea Propanediol sold by Dupont Tate and Lyle Bioproducts). d) Enzymatic inhibitors
  • the deodorant active agents may also be enzyme inhibitors such as triethyl citrate; or alum.
  • some of the active agents mentioned above may be incorporated into spherules, especially ionic or nonionic vesicles and/or nanoparticles (nanocapsules and/or nanospheres).
  • the deodorant active agents may be present in the composition according to the invention in a proportion of from 0.001 to 40% by weight relative to the total weight of the composition, and preferably in a proportion of from 0.1 to 25% by weight.
  • compositions according to the invention contain at least one water-immiscible organic liquid phase, known as an oil phase.
  • This phase generally comprises one or more hydrophobic compounds that make said phase water-immiscible.
  • Said phase is liquid at ambient temperature (20-25°C).
  • the oil phase is present in concentrations ranging from 1 to 60% by weight and more preferentially from 4 to 40% by weight relative to the total weight of the composition.
  • the oil phase of the emulsions in accordance with the invention comprises at least one volatile hydrocarbon-based oil.
  • the volatile hydrocarbon-based oil is chosen in particular from hydrocarbon- based oils containing from 8 to 16 carbon atoms, and especially Cs-Ci6 isoalkanes (also known as isoparaffins), for instance isododecane (also known as 2,2,4,4,6- pentamethylheptane), isodecane and isohexadecane, for example the oils sold under the trade names Isopar or Permethyl, branched Cs-Ci6 esters and isohexyl neopentanoate, and mixtures thereof.
  • Cs-Ci6 isoalkanes also known as isoparaffins
  • isododecane also known as 2,2,4,4,6- pentamethylheptane
  • isodecane and isohexadecane for example the oils sold under the trade names Isopar or Permethyl, branched Cs-Ci6 esters and isohexyl neopentanoate, and
  • Use may also be made of other volatile hydrocarbon-based oils, such as petroleum distillates, in particular those sold under the name Shell Solt by the company Shell; and volatile linear alkanes, such as those described in patent application DE10 2008 012 457 by the company Cognis.
  • volatile hydrocarbon-based oils such as petroleum distillates, in particular those sold under the name Shell Solt by the company Shell
  • volatile linear alkanes such as those described in patent application DE10 2008 012 457 by the company Cognis.
  • the volatile hydrocarbon-based oil is chosen from Cs-Ci6 isoalkanes and particularly, from isododecane, isodecane, isohexadecane and mixtures thereof and even more particularly isododecane.
  • the volatile hydrocarbon-based oil(s) are present in concentrations ranging from 0.1 to 100% by weight and more preferentially from 1 to 80% by weight relative to the total weight of the oil phase.
  • the volatile hydrocarbon-based oil(s) are present in concentrations ranging from 0.1 to 30% and more preferentially from 0.5 to 15% relative to the total weight of the composition.
  • the oil phase of the emulsions in accordance with the invention comprises at least one additional oil.
  • the additional oil may be chosen from mineral, vegetable, synthetic oils; particularly non-volatile hydrocarbon-based oils and/or non-volatile or volatile silicones, volatile or non-volatile fluorinated oils and mixtures thereof.
  • the additional oil(s) are present in concentrations ranging from 0.1 to 99% by weight and more preferentially from 0.1 to 90% by weight relative to the total weight of the oil phase.
  • non-volatile oil is intended to mean an oil that remains on the skin or the keratin fiber at ambient temperature and atmospheric pressure for at least several hours, and that especially has a vapor pressure of less than 10 "3 mmHg (0.13 Pa).
  • the volatile silicones may be chosen from volatile linear or cyclic silicone oils, in particular those with a viscosity of ⁇ 8 centistokes
  • silicone oils that may be used in the invention, mention may be made especially of octamethylcyclotetrasiloxane, decamethyl- cyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethylhexyl- trisiloxane, heptamethyloctyltrisiloxane, hexamethyldisiloxane, octamethyl- trisiloxane, decamethyltetrasiloxane and dodecamethylpentasiloxane and mixtures thereof.
  • R represents an alkyl group comprising from 2 to 4 carbon atoms, one or more hydrogen atoms of which may be replaced with a fluorine or chlorine atom.
  • R represents an alkyl group comprising from 2 to 4 carbon atoms, one or more hydrogen atoms of which may be replaced with a fluorine or chlorine atom.
  • non-volatile oils that may be used in the invention, mention may be made of:
  • hydrocarbon-based oils of plant origin such as liquid triglycerides of fatty acids containing from 4 to 24 carbon atoms, for instance caprylic/capric acid triglycerides such as those sold by the company Stearineries Dubois or those sold under the names Miglyol 810, 812 and 818 by the company Dynamit Nobel;
  • linear or branched hydrocarbons of mineral or synthetic origin such as liquid paraffins and derivatives thereof, petroleum jelly, polydecenes, polybutenes, hydrogenated polyisobutene, such as Parleam, or squalane;
  • synthetic ethers having from 10 to 40 carbon atoms, such as propylene glycols and their derivatives such as PPG14 butyl ether;
  • esters especially of fatty acids, isononyl isononanoate, isopropyl myristate, isopropyl palmitate, C12-C15 alcohol benzoates, hexyl laurate, diisopropyl adipate, 2-ethylhexyl palmitate, 2-octyldodecyl stearate, 2-octyldodecyl erucate, isostearyl isostearate;
  • - fatty alcohols that are liquid at ambient temperature, containing a branched and/or unsaturated carbon-based chain containing from 12 to 26 carbon atoms, for instance octyldodecanol, isostearyl alcohol, 2-butyloctanol, 2-hexyldecanol, 2- undecylpentadecanol or oleyl alcohol;
  • fluoro oils that are optionally partially hydrocarbon-based and/or silicone-based, for instance fluorosilicone oils, fluoropolyethers and fluorosilicones as described in the document EP-A-847 752;
  • silicone oils for instance non-volatile polydimethylsiloxanes (PDMSs); phenyl silicones, for instance phenyl trimethicones, phenyl dimethicones, phenyl- trimethylsiloxydiphenylsiloxanes, diphenyl dimethicones, diphenylmethyl- diphenyltrisiloxanes, 2-phenylethyl trimethylsiloxysilicat.es, and
  • At least one non-volatile silicone oil will be used, and more preferentially, a polydimethylsiloxane (INCI name: Dimethicone).
  • the non-volatile silicone oil(s) or the additionals are present in concentrations ranging from 0.1 to 99% by weight and more preferentially from 0.1 to 90% by weight relative to the total weight of the oil phase.
  • the aqueous phase is present in concentrations ranging from 1 to 95% by weight and more preferentially from 50 to 80% by weight relative to the total weight of the composition.
  • the aqueous phase of said compositions contains water and may contain other water-soluble or water-miscible solvents.
  • the water-soluble or water-miscible solvents comprise short chain, for example Ci-C 4 , monoalcohols, such as ethanol or isopropanol; diols or polyols, for instance ethylene glycol, 1 ,2-propylene glycol, 1 ,3-butylene glycol, hexylene glycol, diethylene glycol, dipropylene glycol, 2- ethoxyethanol, diethylene glycol monomethyl ether, triethylene glycol monomethyl ether and sorbitol.
  • Propylene glycol and glycerol, propane-1 ,3-diol will be used more particularly.
  • the emulsion comprises:
  • HDI hexamethylene diisocyanate
  • the cosmetic compositions according to the invention may also comprise cosmetic adjuvants chosen from emollients, antioxidants, opacifiers, stabilizers, moisturizers, vitamins, bactericides, preserving agents, polymers, fragrances, a structuring agent for a fatty phase, in particular chosen from waxes, pasty compounds, mineral or organic lipophilic gelling agents; organic or mineral fillers; thickeners or suspending agents, or any other ingredient normally used in cosmetics for this type of application.
  • cosmetic adjuvants chosen from emollients, antioxidants, opacifiers, stabilizers, moisturizers, vitamins, bactericides, preserving agents, polymers, fragrances, a structuring agent for a fatty phase, in particular chosen from waxes, pasty compounds, mineral or organic lipophilic gelling agents; organic or mineral fillers; thickeners or suspending agents, or any other ingredient normally used in cosmetics for this type of application.
  • the wax is in general a lipophilic compound that is solid at room temperature (25°C), with a reversible solid/liquid change in state, having a melting point of greater than or equal to 30°C, which may be up to 200°C and in particular up to 120°C.
  • the waxes that are suitable for the invention may have a melting point of greater than or equal to 45°C and in particular of greater than or equal to 55°C.
  • the melting point corresponds to the temperature of the most endothermic peak observed in thermal analysis (DSC) as described in the standard ISO 1 1357-3; 1999.
  • the melting point of the wax may be measured using a differential scanning calorimeter (DSC), for example the calorimeter sold under the name MDSC 2920 by the company TA Instruments.
  • the measuring protocol is as follows:
  • a sample of 5 mg of wax placed in a crucible is subjected to a first temperature rise ranging from -20°C to 100°C, at a heating rate of 10°C/minute, it is then cooled from 100°C to -20°C at a cooling rate of 10°C/minute and it is finally subjected to a second temperature rise ranging from -20°C to 100°C at a heating rate of 5°C/minute.
  • the variation in the difference in power absorbed by the empty crucible and by the crucible containing the sample of wax is measured as a function of the temperature.
  • the melting point of the compound is the temperature value corresponding to the top of the peak of the curve representing the variation in the difference in power absorbed as a function of the temperature.
  • the waxes that may be used in the compositions according to the invention are chosen from waxes that are solid at room temperature of animal, plant, mineral or synthetic origin, and mixtures thereof.
  • waxes that are suitable for the invention, mention may be made in particular of hydrocarbon waxes, for instance beeswax, lanolin wax, Chinese insect waxes, rice bran wax, carnauba wax, candelilla wax, ouricury wax, esparto wax, berry wax, shellac wax, Japan wax and sumac wax; montan wax, orange wax and lemon wax, refined sunflower wax sold under the name Sunflower Wax by Koster Keunen, microcrystalline waxes, paraffins and ozokerite; polyethylene waxes, the waxes obtained by the Fischer-Tropsch synthesis and waxy copolymers, and also esters thereof.
  • hydrocarbon waxes for instance beeswax, lanolin wax, Chinese insect waxes, rice bran wax, carnauba wax, candelilla wax, ouricury wax, esparto wax, berry wax, shellac wax, Japan wax and sumac wax
  • montan wax orange wax and lemon wax
  • Mention may also be made of waxes obtained by catalytic hydrogenation of animal or plant oils containing linear or branched C8-C32 fatty chains. Mention may in particular be made, among these waxes, of isomerized jojoba oil, such as the trans-isomerized partially hydrogenated jojoba oil manufactured or sold by the company Desert Whale under the commercial reference lso-Jojoba-50®, hydrogenated sunflower oil, hydrogenated castor oil, hydrogenated coconut oil, hydrogenated lanolin oil and bis(1 ,1 ,1 -trimethylolpropane) tetrastearate, sold under the name Hest 2T-4S® by the company Heterene.
  • isomerized jojoba oil such as the trans-isomerized partially hydrogenated jojoba oil manufactured or sold by the company Desert Whale under the commercial reference lso-Jojoba-50®, hydrogenated sunflower oil, hydrogenated castor oil, hydrogenated coconut oil, hydrogenated lanolin oil and bis(1 ,1
  • silicone waxes C3o -4 5 alkyl dimethicone
  • fluorinated waxes C3o -4 5 alkyl dimethicone
  • waxes obtained by hydrogenation of castor oil esterified with cetyl alcohol sold under the names Phytowax ricin 16L64® and 22L73® by the company Sophim. Such waxes are described in Application FR-A- 2 792 190.
  • wax use may be made of a C2o-C 4 o alkyl (hydroxystearyloxy)stearate
  • Such a wax is sold in particular under the names Kester Wax K 82 P®, Hydroxypolyester K 82 P® and Kester Wax K 80 P® by the company Koster Keunen.
  • microwaxes that may be used in the compositions according to the invention, mention may be made especially of carnauba microwaxes, such as the product sold under the name MicroCare 350® by the company Micro Powders, synthetic microwaxes, such as the product sold under the name MicroEase 1 14S® by the company Micro Powders, microwaxes consisting of a mixture of carnauba wax and polyethylene wax, such as the products sold under the names Micro Care 300® and 310® by the company Micro Powders, microwaxes consisting of a mixture of carnauba wax and of synthetic wax, such as the product sold under the name Micro Care 325® by the company Micro Powders, polyethylene microwaxes, such as the products sold under the names Micropoly 200®, 220®, 220L® and 250S® by the company Micro Powders, the commercial products Performalene 400 Polyethylene® and Performalene 500-L Polyethylene® from New Phase Technologies, Performalene 655 Polyethylene® or paraffin waxes, for instance the wax having the INC
  • the term "pasty compound” is intended to mean a lipophilic fatty compound which exhibits a reversible solid/liquid change of state, which exhibits, in the solid state, an anisotropic crystal arrangement and which comprises, at the temperature of 23°C, a liquid fraction and a solid fraction.
  • the pasty compound is preferably chosen from synthetic compounds and compounds of plant origin.
  • a pasty compound can be obtained by synthesis from starting products of plant origin.
  • the pasty compound may be advantageously chosen from: - lanolin and derivatives thereof,
  • Mineral lipophilic gelling agents that may be mentioned include optionally modified clays, for instance hectorites modified with a C10-C22 ammonium chloride, for instance hectorite modified with distearyldimethylammonium chloride, for instance the product sold under the name Bentone 38V® by the company Elementis.
  • fumed silica optionally hydrophobically treated at the surface, the size of the particles of which is less than 1 ⁇ . This is because it is possible to chemically modify the surface of the silica, by chemical reaction generating a reduction in the number of silanol groups present at the surface of the silica. It is possible in particular to replace silanol groups with hydrophobic groups: a hydrophobic silica is then obtained.
  • the hydrophobic groups can be trimethylsiloxyl groups, which are obtained in particular by treatment of fumed silica in the presence of hexamethyldisilazane. Silicas thus treated are named "silica silylate" according to the CTFA (8th edition, 2000).
  • Silicas thus treated are known as "silica dimethyl silylate" according to the CTFA (8th edition, 2000). They are sold, for example, under the references Aerosil R972® and Aerosil R974® by the company Degussa, and Cab-O-Sil TS-610® and Cab-O-Sil TS-720® by the company Cabot.
  • the hydrophobic fumed silica in particular has a particle size that may be nanometric to micrometric, for example ranging from about 5 to 200 nm.
  • the polymeric organic lipophilic gelling agents are, for example, partially or totally crosslinked elastomeric organopolysiloxanes of three-dimensional structure, for instance those sold under the names KSG6®, KSG16® and KSG18® from Shin- Etsu, Trefil E-505C® or Trefil E-506C® from Dow Corning, Gransil SR-CYC®, SR DMF10®, SR-DC556®, SR 5CYC gel®, SR DMF 10 gel® and SR DC 556 gel® from Grant Industries and SF 1204® and JK 1 13® from General Electric; ethylcellulose, for instance the product sold under the name Ethocel® by Dow Chemical; galactomannans comprising from one to six and in particular from two to four hydroxyl groups per saccharide, substituted with a saturated or unsaturated alkyl chain, for instance guar gum alkylated with Ci to C6, and in particular Ci to C3, alkyl chains, and mixtures thereof.
  • Block copolymers of "diblock”, “triblock” or “radial” type, of the polystyrene/polyisoprene or polystyrene/polybutadiene type such as the products sold under the name Luvitol HSB® by the company BASF, of the polystyrene/copoly(ethylene-propylene) type, such as the products sold under the name Kraton® by the company Shell Chemical Co., or of the polystyrene/copoly(ethylene-butylene) type, and mixtures of triblock and radial (star) copolymers in isododecane, such as those sold by the company Penreco under the name Versagel®, for instance the mixture of butylene/ethylene/styrene triblock copolymer and of ethylene/propylene/styrene star copolymer in isododecane (Versagel M 5960).
  • lipophilic gelling agents which can be used in the compositions according to the invention, of esters of dextrin and of fatty acid, such as dextrin palmitates, in particular such as those sold under the names Rheopearl TL® or Rheopearl KL® by the company Chiba Flour. It is also possible to use silicone polyamides of the polyorganosiloxane type such as those described in documents US-A-5 874 069, US-A-5 919 441 , US-A-6 051 216 and US-A-5 981 680.
  • the thickeners can be chosen from carboxyvinyl polymers, such as the Carbopols (Carbomers) and the Pemulens (acrylate/Cio-C3o alkyl acrylate copolymer); polyacrylamides, such as, for example, the crosslinked copolymers sold under the names Sepigel 305 (CTFA name: polyacrylamide/Ci3-i 4 isoparaffin/laureth 7) or Simulgel 600 (CTFA name: acrylamide/sodium acryloyldimethyltaurate copolymer/isohexadecane/polysorbate 80) by the company Seppic; optionally crosslinked and/or neutralized polymers and copolymers of 2-acrylamido-2- methylpropanesulfonic acid, such as the poly(2-acrylamido-2- methylpropanesulfonic acid) sold by the company Hoechst under the trade name Hostacerin AMPS (CTFA name: ammonium polyacryloyldi
  • the thickeners can also be cationic, such as, for example, Polyquaternium-37, sold under the name Salcare SC95 (Polyquaternium-37 (and) Mineral Oil (and) PPG-1 Trideceth-6) or Salcare SC96 (Polyquaternium-37 (and) Propylene Glycol Dicaprylate/Dicaprate (and) PPG-1 Trideceth-6), or other crosslinked cationic polymers, such as, for example, those having the CTFA name Ethyl Acrylate/Dimethylaminoethyl Methacrylate Cationic Copolymer In Emulsion.
  • Salcare SC95 Polyquaternium-37 (and) Mineral Oil (and) PPG-1 Trideceth-6)
  • Salcare SC96 Polyquaternium-37 (and) Propylene Glycol Dicaprylate/Dicaprate (and) PPG-1 Trideceth-6
  • CTFA crosslinked cationic polymers
  • compositions according to the invention will additionally comprise an organic powder.
  • organic powder means any solid that is insoluble in the medium at room temperature (25°C).
  • suspending agents which are preferably chosen from hydrophobic modified montmorillonite clays, such as hydrophobic modified bentonites or hectorites.
  • CTFA name Stearalkonium Bentonite
  • Other suspending agents can be used, in this case in hydrophilic (aqueous and/or ethanolic) media. They can be derivatives of cellulose, xanthan, guar, star
  • the amounts of these various constituents that may be present in the cosmetic composition according to the invention are those conventionally used in deodorant compositions.
  • the amounts of these various constituents that may be present in the cosmetic composition according to the invention are those conventionally used in deodorant compositions.
  • composition according to the invention may be presented in the form of a cream of varying thickness distributed in a tube or in a grating; in the form of a roll-on (packaged in ball form) and contain for this purpose the ingredients generally used in this type of product and well known to the person skilled in the art.
  • the composition is presented in the form of a roll-on.
  • the emulsions in accordance with the invention may be prepared according to the standard techniques used for preparing oil-in-water emulsions. They can be obtained according to a process comprising at least the following steps:
  • the mixture comprising at least one alkylpolyglycoside whose alkyl chain is linear or branched and comprises from 12 to 22 carbon atoms and at least one linear or branched fatty alcohol, having from 12 to 22 carbon atoms and heated to a temperature greater than or equal to 70°C (for example 80°C); and
  • step 2 preparation of the aqueous phase with polyether polyurethane and heating to the same temperature as step 1 ); c) addition of the mixture obtained in step 1 ) to the mixture obtained in step 2) with stirring then the entirety is cooled to a temperature less than or equal to 50°C (for example 40°C);
  • Dimethicone and the glucoside derivative are added to a beaker and heated to 80°C with stirring.
  • the water and copolymer are mixed together with stirring to disperse and heated to 80°C.
  • the premix from beaker 1 is added, with strong stirring, then the entirety is cooled to 40°C.
  • the aluminum salts are added with stirring, then the other ingredients, with the perlite last.
  • the fragrance was added around 25°C.
  • the product studied is spread on a specific substrate constituted of a PMMA plate onto which a substrate simulating the appearance of skin (SUPPLALE® substrate - reference PBZ13001 from Idemitsu). Spreading is done using a finger cot on the SUPPLALE substrate in a circle defined by a two-sided crown. The amount of product spread is 3.75 mg/cm 2 .
  • the plate with the film is placed under the texture analyzer - Model TA-XT2 from company Stable Micro Systems - equipped with a cylindrical probe which is 18 mm in diameter, to which an 18 mm disk of Bioskin support (Bioskin plate black K275 from Maprecos SAS) has been attached - and has been covered with a SUPPLALE support.
  • TA-XT2 from company Stable Micro Systems - equipped with a cylindrical probe which is 18 mm in diameter, to which an 18 mm disk of Bioskin support (Bioskin plate black K275 from Maprecos SAS) has been attached - and has been covered with a SUPPLALE support.
  • the texture analyzer is placed in a glovebox so as to work in a temperature- and humidity-controlled atmosphere (temperature of 37°C and relative humidity of 40%).
  • the probe will "compress” the product with a determined force.
  • the apparatus then calculates the force required for the probe to separate from the sample. In the case of the experiment, only the maximum force expressed in grams, which represents the strength of the tackiness of the formula at this given moment, is retained. This type of measurement is made at different times (every 30 seconds) until a "zero" ( * ) force is obtained, which means that the film of the formula studied is dry.
  • the plot is a histogram showing the maximum force, which represents the intensity of the tackiness of the formula.
  • composition 1 according to the invention comprising the volatile hydrocarbon-based oil (isododecane) reduces the tackiness of composition 2 without isododecane by 50%.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
  • Polyurethanes Or Polyureas (AREA)

Abstract

La présente invention concerne une émulsion huile-dans-l'eau comprenant : a) au moins une phase aqueuse continue ; et b) au moins une phase huileuse dispersée dans ladite phase aqueuse et comprenant au moins une huile à base d'hydrocarbure volatil ; et c) au moins un mélange comprenant au moins un alkylpolyglycoside dont la chaîne alkyle est linéaire ou ramifiée et comprend de 12 à 22 atomes de carbone et au moins un alcool gras linéaire ou ramifié, ayant de 12 à 22 atomes de carbone ; d) au moins un polyéther-polyuréthane non ionique associatif ; e) au moins un agent actif déodorant. La présente invention concerne également un procédé de traitement de l'odeur corporelle et éventuellement de la transpiration humaine, qui consiste à appliquer sur une matière kératinique une émulsion telle que définie précédemment.
EP15808602.5A 2014-12-12 2015-12-11 Émulsion de déodorant contenant un mélange d'alkylpolyglycoside et d'alcool gras, un polyuréthane-polyéther non ionique associatif, une huile à base d'hydrocarbure volatil Withdrawn EP3229759A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1462358A FR3032613B1 (fr) 2014-12-12 2014-12-12 Emulsion deodorante contenant un melange d'alkylpolyglycoside et d'alcool gras, un polyether polyurethane non-ionique associatif, une huile hydrocarbonee volatile
PCT/EP2015/079504 WO2016092107A1 (fr) 2014-12-12 2015-12-11 Émulsion de déodorant contenant un mélange d'alkylpolyglycoside et d'alcool gras, un polyuréthane-polyéther non ionique associatif, une huile à base d'hydrocarbure volatil

Publications (1)

Publication Number Publication Date
EP3229759A1 true EP3229759A1 (fr) 2017-10-18

Family

ID=52684404

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15808602.5A Withdrawn EP3229759A1 (fr) 2014-12-12 2015-12-11 Émulsion de déodorant contenant un mélange d'alkylpolyglycoside et d'alcool gras, un polyuréthane-polyéther non ionique associatif, une huile à base d'hydrocarbure volatil

Country Status (6)

Country Link
EP (1) EP3229759A1 (fr)
BR (1) BR112017010231A2 (fr)
FR (1) FR3032613B1 (fr)
MX (1) MX2017007129A (fr)
RU (1) RU2692476C2 (fr)
WO (1) WO2016092107A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102019126256A1 (de) * 2019-09-30 2021-04-01 Henkel Ag & Co. Kgaa Nachhaltige Deo-Emulsion für Roll-on Deo mit antibakterieller Wirkung, Deo, umfassend dieselbe und Verwendung des Deos
FR3108034B1 (fr) 2020-03-11 2022-09-09 Hyteck Composition deodorante
WO2021237317A1 (fr) * 2020-05-29 2021-12-02 L'oreal Composition antitranspirante, son procédé de production et son utilisation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792068A (en) 1971-04-02 1974-02-12 Procter & Gamble Dry powder aerosol antiperspirant composition incorporating dry powder antiperspirant active complex and process for its preparation
DE3760959D1 (en) 1986-01-10 1989-12-14 Ciba Geigy Ag Lubricant additives containing sulphur and nitrogen
FR2668080B1 (fr) 1990-10-17 1993-08-13 Seppic Sa Compositions auto-emulsionnables a base d'alcools gras, leur procede de preparation et leur utilisation pour la realisation d'emulsions.
FR2712595B1 (fr) 1993-11-19 1995-12-22 Seppic Sa Un concentré comportant des alkylglycosides et ses utilisations.
US5919441A (en) 1996-04-01 1999-07-06 Colgate-Palmolive Company Cosmetic composition containing thickening agent of siloxane polymer with hydrogen-bonding groups
US5874069A (en) 1997-01-24 1999-02-23 Colgate-Palmolive Company Cosmetic composition containing silicon-modified amides as thickening agents and method of forming same
FR2756176B1 (fr) 1996-11-26 1998-12-18 Oreal Composition cosmetique comprenant un compose fluore et presentant un confort ameliore
FR2762317B1 (fr) 1997-04-21 1999-07-09 Seppic Sa Composition a base d'alkylpolyglycosides et d'alcools gras, et ses utilisations
US6051216A (en) 1997-08-01 2000-04-18 Colgate-Palmolive Company Cosmetic composition containing siloxane based polyamides as thickening agents
US5981680A (en) 1998-07-13 1999-11-09 Dow Corning Corporation Method of making siloxane-based polyamides
FR2792190B1 (fr) 1999-04-16 2001-09-28 Sophim Procede de fabrication d'un emollient non gras a base de cires-esters
FR2863490B1 (fr) * 2003-12-16 2006-05-19 Oreal Composition deorante du type emulsion huile-dans-eau contenant un melange d'alkylpolyglycoside et d'alcool gras et un polyether polyurethane non-ionique associatif
US7976828B2 (en) * 2007-02-02 2011-07-12 Colgate-Palmolive Company Antiperspirant/deodorant composition
DE102008012457A1 (de) 2007-06-19 2008-12-24 Cognis Ip Management Gmbh Kohlenwasserstoff Gemische und ihre Verwendung
FR3002141B1 (fr) * 2013-02-21 2015-06-26 Oreal Emulsion huile-dans-eau comprenant au moins un melange specifique de tensioactifs non-ioniques, une cire comprenant au moins un ester et un polysaccharide hydrosoluble

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO2016092107A1 *

Also Published As

Publication number Publication date
FR3032613A1 (fr) 2016-08-19
RU2692476C2 (ru) 2019-06-25
RU2017124440A (ru) 2019-01-14
BR112017010231A2 (pt) 2018-02-14
FR3032613B1 (fr) 2017-02-17
WO2016092107A1 (fr) 2016-06-16
MX2017007129A (es) 2017-08-18
RU2017124440A3 (fr) 2019-01-14

Similar Documents

Publication Publication Date Title
US11266583B2 (en) Cosmetic method for treating human perspiration using particles of an expanded amorphous mineral material; compositions
JP6001051B2 (ja) ４−（３−エトキシ−４−ヒドロキシフェニル）アルキルケトン化合物または２−エトキシ−４−ヒドロキシアルキルフェノール化合物を使用するヒトの体臭を処置する美容方法
US8636990B2 (en) Use of expanded amorphous mineral particles for increasing the tenacity of a fragrance, scenting composition and method for treating body odours
EP2734175B1 (fr) Utilisation, comme anti-transpirant, d'un sel de cation multivalent sans anti-transpirant de type halogénure d'aluminium ou composé apte à réagir avec ledit sel afin de produire un effet anti-transpirant
JP2020504125A (ja) マグネシウム塩を含む無水組成物
EP2900201B1 (fr) Émulsion antiperspirante huile-dans-eau, comprenant un sel ou complexe antiperspirant d'aluminium et/ou de zirconium et un polymère éthylénique filmogène séquencé insoluble dans l'eau
RU2692476C2 (ru) Дезодорант в виде эмульсии, содержащей смесь алкилполигликозида и жирного спирта, ассоциативного неионного полиэфир-полиуретана, летучее масло на углеводородной основе
RU2664701C2 (ru) Косметическая композиция, содержащая комбинацию липофильного производного салициловой кислоты, антиперспирантной соли или комплекса алюминия и соли аминокислота-n,n-диуксусной кислоты
US10307365B2 (en) Cosmetic use of a geraniol-rich essential oil of Satureja montana as deodorant active agent
JP2018193397A (ja) 消臭活性剤としての、一価不飽和脂肪酸、又はその塩の及び／又はそのエステルの１つの美容的使用
EP2900335B1 (fr) Procédé de protection de la couleur d'un matériau textile au moyen d'une émulsion huile-dans-eau contenant un mélange d'un alkylpolyglycoside et d'un alcool gras et un polyuréthane-polyéther associatif non ionique
EP2642974B1 (fr) Procédé de traitement de la transpiration utilisant un composé de carbonyle capable de réagir via la réaction de maillard
WO2011047982A2 (fr) Utilisation d'adénosine et/ou d'un de ses dérivés en tant qu'agent pour le traitement de la transpiration humaine

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170712

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20181017

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20201208